The Effectiveness of Ledipasvir/Sofosbuvir in Youth With Genotype 4 Hepatitis C Virus
- 1 January 2019
- journal article
- research article
- Published by Wolters Kluwer Health in The Pediatric Infectious Disease Journal
- Vol. 38 (1) , 22-25
Abstract
Background: Licensure of ledipasvir/sofosbuvir for chronic hepatitis C virus (HCV) infection in adolescents was based on clinical trials on patients mainly with genotype 1. We aimed to evaluate the effectiveness and short-term safety of this newly approved antiviral in adolescents with HCV genotype 4.Methods: This was a study of 51 HCV-infected adolescents, who received the adult dose of ledipasvir/sofosbuvir, once daily for 12 weeks, and were followed-up for 12 weeks post-treatment. Laboratory tests, quantitation of HCV RNA, HCV genotyping, IL-28rs gene polymorphism and transient elastography were performed at baseline. Follow-up visits were done for blood testing and adverse events recording.Results: The mean age was 14.7 ± 1.5 years (11–17.5), with a male to female ratio of 1.7:1. All patients were genotype 4a, and 76.5% had the CC IL-28 gene polymorphism. About 50% gave a history of HCV-infected mother, and 31% were treatment-experienced. Liver stiffness was F0 in 72.5%, F0–F1 in 13.7% and F1–F2 in 13.7%. Adverse events were mainly abdominal pain in 72.5%, headache in 64.7% and diarrhea in 53% of patients; these were mild. A reversible increase in creatinine level with a concomitant decline in estimated glomerular filtration rate was observed in the first month of treatment. By the end of week 12, a significant decline in liver enzymes was observed. All patients achieved an early, end of treatment, and a sustained virologic response.Conclusions: Adolescent patients with genotype 4 chronic HCV infection achieved a good response rate with good ontreatment tolerability for ledipasvir/sofosbuvir therapy.Keywords
This publication has 21 references indexed in Scilit:
- Ledipasvir and Sofosbuvir for Untreated HCV Genotype 1 InfectionNew England Journal of Medicine, 2014
- Ledipasvir and Sofosbuvir for Previously Treated HCV Genotype 1 InfectionNew England Journal of Medicine, 2014
- Eradication of Hepatitis C Virus Infection and the Development of Hepatocellular CarcinomaAnnals of Internal Medicine, 2013
- Treatment of Hepatitis C in Children: A Systematic ReviewPLOS ONE, 2010
- Hepatocellular Carcinoma in 2 Young Adolescents With Chronic Hepatitis CJournal of Pediatric Gastroenterology and Nutrition, 2009
- Transient elastography (FibroScan)Gastroentérologie Clinique Et Biologique, 2008
- Long-Term Course of Chronic Hepatitis C in Children: From Viral Clearance to End-Stage Liver DiseaseGastroenterology, 2008
- Pathology of chronic hepatitis C in children: Liver biopsy findings in the Peds-C TrialHepatology, 2008
- The natural history of hepatitis C virus in pediatric liver transplant recipientsLiver Transplantation, 2006
- Histopathology of the Liver in Children With Chronic Hepatitis C Viral InfectionHepatology, 1998